Konstantinos Alataris
unknown
Konstantinos Alataris is set to join the board of Oryzon Genomics, contributing his expertise in biotechnology and strategic development to support the company's growth and advancements in psychiatric treatment.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Spain:
Konstantinos Alataris is proposed to be a new member of the Oryzon board.
5
Carlos Buesa
Pierre Beaurang
Montse Vendrell
Luis Sanchez Quintana
Ramon Adell
Isabel Aguilera
Antonio Fornieles
Josep Maria Echarri
Tamara Maes
El País: Oryzon duplica su valor en Bolsa desde enero con sus últimos avances en tratamientos en psiquiatría | Empresas